These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24834438)

  • 1. New Prognostic Markers: The Pathway from Research to Clinical Practice.
    Savage C; Vickers AJ
    Grand rounds Urol; 2009 Aug; 8(3):7-13. PubMed ID: 24834438
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic markers in renal cell carcinoma: A focus on the 'mammalian target of rapamycin' pathway.
    Youssef RF; Cost NG; Darwish OM; Margulis V
    Arab J Urol; 2012 Jun; 10(2):110-7. PubMed ID: 26558012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases.
    Wang G; Ouyang J; Li S; Wang H; Lian B; Liu Z; Xie L
    J Transl Med; 2019 Aug; 17(1):264. PubMed ID: 31409386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review.
    de Ruijter TC; van der Heide F; Smits KM; Aarts MJ; van Engeland M; Heijnen VCG
    Breast Cancer Res; 2020 Jan; 22(1):13. PubMed ID: 32005275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
    Colozza M; Azambuja E; Cardoso F; Sotiriou C; Larsimont D; Piccart MJ
    Ann Oncol; 2005 Nov; 16(11):1723-39. PubMed ID: 15980158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in pulmonary metastasectomy: spotlight on molecular and radiological markers.
    Schweiger T; Lang G; Klepetko W; Hoetzenecker K
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):408-16. PubMed ID: 23729747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry.
    Zeestraten EC; Benard A; Reimers MS; Schouten PC; Liefers GJ; van de Velde CJ; Kuppen PJ
    Biomark Cancer; 2013 Jul; 5():13-29. PubMed ID: 24179395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can biochemical markers for bone density be recommended as diagnostic and prognostic tools in osteoporosis?].
    Midtby M; Magnus JH
    Tidsskr Nor Laegeforen; 1998 Feb; 118(4):575-9. PubMed ID: 9520586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic markers in chronic lymphocytic leukaemia.
    Hamblin TJ
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):455-68. PubMed ID: 17707833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic molecular markers in cancer - quo vadis?
    Søland TM; Brusevold IJ
    Histopathology; 2013 Sep; 63(3):297-308. PubMed ID: 23837466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing prognostic and predictive biomarkers in CRC clinical trials.
    Van Schaeybroeck S; Allen WL; Turkington RC; Johnston PG
    Nat Rev Clin Oncol; 2011 Feb; 8(4):222-32. PubMed ID: 21321566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive markers in cancer.
    Conley BA; Taube SE
    Dis Markers; 2004; 20(2):35-43. PubMed ID: 15322312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of systemic inflammatory response markers in urological malignancy.
    Ohno Y
    Int J Urol; 2019 Jan; 26(1):31-47. PubMed ID: 30253448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers in bladder cancer: Novel research frontiers.
    Sanguedolce F; Cormio A; Bufo P; Carrieri G; Cormio L
    Crit Rev Clin Lab Sci; 2015; 52(5):242-55. PubMed ID: 26053693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction in rectal cancer.
    Zeestraten EC; Kuppen PJ; van de Velde CJ; Marijnen CA
    Semin Radiat Oncol; 2012 Apr; 22(2):175-83. PubMed ID: 22385923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor markers. An update approach for their prognostic significance. Part I.
    Agnantis NJ; Goussia AC; Stefanou D
    In Vivo; 2003; 17(6):609-18. PubMed ID: 14758728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-based Markers in the Prognostic Prediction of Esophagogastric Junction Cancer.
    Liu CT; Hong CQ; Huang XC; Li EM; Xu YW; Peng YH
    J Cancer; 2020; 11(15):4332-4342. PubMed ID: 32489452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice.
    Doubek M; Mayer J; Obrtlíková P; Smolej L; Cmunt E; Schwarz J; Brejcha M; Kozmon P; Pospíšilová S; Brychtová Y; Pospíšil Z; Trněný M
    Eur J Haematol; 2011 Aug; 87(2):130-7. PubMed ID: 21535162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
    Draht MXG; Goudkade D; Koch A; Grabsch HI; Weijenberg MP; van Engeland M; Melotte V; Smits KM
    Clin Epigenetics; 2018; 10():35. PubMed ID: 29564023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.